← Leaderboards
Sarah Abdulla Molokhia
Iveena Delivery Systems, Inc.
$3,184,060
Attributed
$3,184,060
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $933.8K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,184,060 · 4
By mechanism
R44$2,614,293 · 2
R43$569,767 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Toxicology”
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Matthew Johnson · Duke University$56,071,536
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$44,140,914
- Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn$40,089,913
Research focus
ToxicologyCrosslinkTechnologyCorneaLinkEyedropsOryctolagus CuniculusFormulationTissuesDesignProtein-Lysine 6-OxidaseSmall Business Innovation Research GrantBiochemicalDoseCopperCollagenAnimal ModelSafetyPharmacologic SubstanceEvaluationBiomechanicsMyopiaCataractOperative Surgical Procedures
Grant awards (5)
Topical Eyedrops Increasing Lysyl Oxidase and Dopamine Activity to Control Myopia$933,817
R44 · FY2025 · EY · contact PI
Topical Eyedrops Increasing Lysyl Oxidase Activity to Control Myopia$345,000
R43 · FY2023 · EY · contact PI
Topical Eyedrop Therapy for Keratoconus$909,474
R44 · FY2021 · EY · contact PI
Topical Eyedrop Therapy for Keratoconus$771,002
R44 · FY2020 · EY · contact PI
Topical Eyedrop Therapy for Keratoconus$224,767
R43 · FY2017 · EY · contact PI